Laser treatment could offer new hope for chronic skin condition

NCT ID NCT03926299

Completed Disease control Sponsor: Prof. Dr. Volker Viereck Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new dual laser treatment for vulvar lichen sclerosus, a chronic skin condition causing discomfort. 66 participants were randomly assigned to receive either laser therapy or standard steroid cream. The goal was to see if the laser works as well as the cream, potentially offering a non-steroid option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dual laser therapy (Nd:YAG and Er:YAG)
What this could lead to: If successful, this laser treatment could offer an effective alternative to steroid creams for managing vulvar lichen sclerosus, potentially reducing side effects from long-term steroid use.
What could go wrong: This is a small, completed trial with only 66 participants. The results may not apply to everyone, and laser therapy might not be as effective as steroids for all patients. Long-term effects are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SKIN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vulvar lichen sclerosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC SKIN DISEASE VULVAR LICHEN SCLEROSUS

Contacts and locations

Locations

Cantonal Hospital Frauenfeld

Frauenfeld, Thurgau, 8501, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.